drugset / Trial / NCT06803290

Food Effect Study of VHX-896 in Healthy Volunteers

NCT06803290

Phase 1 Completed 24 enrolled Vanda Pharmaceuticals
RandomizedCrossoverOpen-labelTreatment

Summary

A single center, two-period, randomized study to evaluate the food effect of VHX-896 tablets in healthy volunteers

Timeline

Start
2022-06-21
Primary completion
2022-12-27
Completion
2022-12-27

Drugs

EvaluationDrugModalityDoseRoute
Subject VHX-896 Unknown Oral

Indications

No indication recorded.